Influence of Cardiovascular and Metabolic Comorbidities on the Severity and Outcomes of Hospital-Acquired Sepsis in ICU Patients: A Case-Control Analysis - Takeaways - MDSpire

Influence of Cardiovascular and Metabolic Comorbidities on the Severity and Outcomes of Hospital-Acquired Sepsis in ICU Patients: A Case-Control Analysis

  • By

  • Amrita Roy

  • Vignesh Krishnasamy

  • Sourabh Mitra

  • Sudip Banerjee

  • Tapan Kumar Dutta

  • Nachimuthu Senthil Kumar

  • Swagnik Roy

  • February 2, 2026

  • 0 min

Share

  • 1

    Sepsis is a leading cause of global mortality, accounting for 19.7% of deaths, with significant regional variations in incidence.

  • 2

    The study investigates the impact of cardiovascular and metabolic comorbidities on the severity of hospital-acquired sepsis in ICU patients.

  • 3

    Inflammatory markers like PCT, IL-6, IL-10, and TNF-α are crucial for understanding the inflammatory profile in sepsis patients.

  • 4

    Septic shock is associated with chronic cardiovascular issues and a high mortality rate, particularly in patients with pre-existing conditions.

  • 5

    The research aims to provide insights into risk stratification and inflammatory burden in sepsis patients from an underrepresented population.

Original Source(s)

Related Content